Shanghai Medicilon Inc. (688202.SH) plans to repurchase company shares worth 50-100 million yuan.
Medisy (688202.SH) announced that the company plans to use its own funds and repurchase special loans through the Shanghai Securities...
Shanghai Medicilon Inc. (688202.SH) announced that the company plans to use its own funds and special repurchase loans to repurchase some of the company's issued Renminbi ordinary shares (A shares) through the Shanghai Stock Exchange trading system in a centralized competitive bidding manner, and will use the repurchased shares for future equity incentives or employee stock ownership plans or to cancel and reduce the company's registered capital at an appropriate time in the future. The total amount of the repurchase funds shall not be less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive), and the repurchase price of the shares shall not exceed RMB 54 per share (inclusive). The repurchase period shall be within 6 months from the date of approval of the repurchase plan by the company's shareholders' meeting.
Related Articles

US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%






